Abstract O11 Table 1

Demographic and transplant data for all 8 prioritised patients. PFIC3; Progressive Familial Intrahepatic Cholestasis type 3, LT; Liver transplantation, NSC; Neonatal Sclerosing Cholangitis, CDG; Congenital Disorder of Glycosylation, AILD; Autoimmune Liver Disease, IFALD; Intestinal Failure Associated Liver Disease

Patient/SexCentreAge at registration
(yrs)
Primary liver diseaseRegistered prior to PrioritisationLTWaiting time on prioritised tier/Time on list prior to prioritisation
1/ 1 0 CDG Yes Yes/LLS 5/27
2/M 2 1 Cryptogenic Cirrhosis Yes Yes/LLS 16/48
3/F 1 15 AILD Yes Yes/whole liver 3/4
4/M 2 0 Biliary Atresia Yes Yes/LLS 14/71
5/F 2 4 IFALD No Yes/LLS 15/820
6/F 2 0 NSC Yes Yes/LLS 37/405
7/M 2 10 Biliary Atresia Yes Yes/reduced R lobe 4/7
8/M 3 9 PFIC3 Yes Yes/LLS 6/51